Melatonin and derivatives as promising tools for glaucoma treatment

doi:10.5318/wjo.v3.i4.32

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 3, Issue 4

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9845)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-1) series.

Item

Count

PDF

471

HTML

6789

Figures (1-3)

262

Tables (1-1)

228

Sum=7750

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1118

Download

977

Sum=2095

Nov 12, 2013 (publication date) through Nov 28, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Ophthalmology

ISSN

2218-6239

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Ophthalmol. Nov 12, 2013; 3(4): 32-37
Published online Nov 12, 2013. doi: 10.5318/wjo.v3.i4.32

Full Size Figure Download Figure

Figure 1 Chemical structure of melatonin and analogues. Melatonin (N-acetyl-5-methoxytryptamine), IIK7 (N-butanoyl-2-(2-methoxy-6H-isoindolo[2,1-a]indol-11-yl)ethanamine) and 5-MCA-NAT (5-methylcarboxyamino-N-acetyltryptamine).

Citation: Alkozi HA, Pintor J. Melatonin and derivatives as promising tools for glaucoma treatment. World J Ophthalmol 2013; 3(4): 32-37
URL: https://www.wjgnet.com/2218-6239/full/v3/i4/32.htm
DOI: https://dx.doi.org/10.5318/wjo.v3.i4.32